de la Cruz-Merino L, Gion M, Cruz J, Alonso-Romero JL, et al. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015-04 (PANGEA-Breast) study. BMC Cancer 2022;22:1258.
PMID: 36463104